Porte D Jr - Search Results

1

A 12-week randomized clinical trial investigating the potential for sucralose to affect glucose homeostasis.

Grotz VL, Pi-Sunyer X, Porte D Jr, Roberts A, Richard Trout J. Grotz VL, et al. Among authors: porte d jr. Regul Toxicol Pharmacol. 2017 Aug;88:22-33. doi: 10.1016/j.yrtph.2017.05.011. Epub 2017 May 11. Regul Toxicol Pharmacol. 2017. PMID: 28502831 Free article. Clinical Trial.

2

The changing landscape of type 2 diabetes: the role of incretin-based therapies in managed care outcomes.

Triplitt C, McGill JB, Porte D Jr, Conner CS. Triplitt C, et al. Among authors: porte d jr. J Manag Care Pharm. 2007 Dec;13(9 Suppl C):S2-16; quiz S17. doi: 10.18553/jmcp.2007.13.9-c.1. J Manag Care Pharm. 2007. PMID: 18062735 Review.

3

Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans.

Porte D Jr, Baskin DG, Schwartz MW. Porte D Jr, et al. Diabetes. 2005 May;54(5):1264-76. doi: 10.2337/diabetes.54.5.1264. Diabetes. 2005. PMID: 15855309 Review.

4

Diabetes, obesity, and the brain.

Schwartz MW, Porte D Jr. Schwartz MW, et al. Among authors: porte d jr. Science. 2005 Jan 21;307(5708):375-9. doi: 10.1126/science.1104344. Science. 2005. PMID: 15662002

5

Leptin and insulin action in the central nervous system.

Porte D Jr, Baskin DG, Schwartz MW. Porte D Jr, et al. Nutr Rev. 2002 Oct;60(10 Pt 2):S20-9; discussion S68-84, 85-7. doi: 10.1301/002966402320634797. Nutr Rev. 2002. PMID: 12403080 Review.

6

Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications.

Porte D Jr. Porte D Jr. Diabetes Metab Res Rev. 2001 May-Jun;17(3):181-8. doi: 10.1002/1520-7560(200105/06)17:3<181::aid-dmrr197>3.0.co;2-1. Diabetes Metab Res Rev. 2001. PMID: 11424231 Review.

7

beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.

Porte D Jr, Kahn SE. Porte D Jr, et al. Diabetes. 2001 Feb;50 Suppl 1:S160-3. doi: 10.2337/diabetes.50.2007.s160. Diabetes. 2001. PMID: 11272181 Review.

8

Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity.

Kahn SE, Prigeon RL, Schwartz RS, Fujimoto WY, Knopp RH, Brunzell JD, Porte D Jr. Kahn SE, et al. Among authors: porte d jr. J Nutr. 2001 Feb;131(2):354S-60S. doi: 10.1093/jn/131.2.354S. J Nutr. 2001. PMID: 11160560 Review.

9

Mechanisms for hyperglycemia in the metabolic syndrome. The key role of beta-cell dysfunction.

Porte D Jr. Porte D Jr. Ann N Y Acad Sci. 1999 Nov 18;892:73-83. doi: 10.1111/j.1749-6632.1999.tb07786.x. Ann N Y Acad Sci. 1999. PMID: 10842653 Review.

10

Central nervous system control of food intake.

Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Schwartz MW, et al. Among authors: porte d jr. Nature. 2000 Apr 6;404(6778):661-71. doi: 10.1038/35007534. Nature. 2000. PMID: 10766253 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results